China · Delayed Price · Currency is CNY Sinocare Statistics
Total Valuation
Sinocare has a market cap or net worth of CNY 8.32 billion. The enterprise value is 8.58 billion.
| Market Cap | 8.32B |
| Enterprise Value | 8.58B |
Important Dates
The next confirmed earnings date is Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Sinocare has 546.53 million shares outstanding. The number of shares has decreased by -1.18% in one year.
| Current Share Class | 546.53M |
| Shares Outstanding | 546.53M |
| Shares Change (YoY) | -1.18% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 51.08% |
| Owned by Institutions (%) | 13.15% |
| Float | 261.81M |
Valuation Ratios
The trailing PE ratio is 70.43 and the forward PE ratio is 20.50.
| PE Ratio | 70.43 |
| Forward PE | 20.50 |
| PS Ratio | 1.71 |
| PB Ratio | 2.43 |
| P/TBV Ratio | 4.38 |
| P/FCF Ratio | 31.25 |
| P/OCF Ratio | 18.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.32, with an EV/FCF ratio of 32.22.
| EV / Earnings | 72.54 |
| EV / Sales | 1.77 |
| EV / EBITDA | 19.32 |
| EV / EBIT | 31.77 |
| EV / FCF | 32.22 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.19 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.80 |
| Debt / FCF | 3.01 |
| Interest Coverage | 7.09 |
Financial Efficiency
Return on equity (ROE) is 1.20% and return on invested capital (ROIC) is 3.52%.
| Return on Equity (ROE) | 1.20% |
| Return on Assets (ROA) | 2.86% |
| Return on Invested Capital (ROIC) | 3.52% |
| Return on Capital Employed (ROCE) | 7.01% |
| Weighted Average Cost of Capital (WACC) | 3.67% |
| Revenue Per Employee | 969,490 |
| Profits Per Employee | 23,597 |
| Employee Count | 5,010 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.57 |
Taxes
In the past 12 months, Sinocare has paid 57.70 million in taxes.
| Income Tax | 57.70M |
| Effective Tax Rate | 56.90% |
Stock Price Statistics
The stock price has decreased by -29.39% in the last 52 weeks. The beta is -0.08, so Sinocare's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | -29.39% |
| 50-Day Moving Average | 15.33 |
| 200-Day Moving Average | 17.23 |
| Relative Strength Index (RSI) | 62.00 |
| Average Volume (20 Days) | 5,966,792 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sinocare had revenue of CNY 4.86 billion and earned 118.22 million in profits. Earnings per share was 0.22.
| Revenue | 4.86B |
| Gross Profit | 2.38B |
| Operating Income | 269.96M |
| Pretax Income | 101.40M |
| Net Income | 118.22M |
| EBITDA | 428.47M |
| EBIT | 269.96M |
| Earnings Per Share (EPS) | 0.22 |
Balance Sheet
The company has 862.39 million in cash and 800.29 million in debt, with a net cash position of 62.11 million or 0.11 per share.
| Cash & Cash Equivalents | 862.39M |
| Total Debt | 800.29M |
| Net Cash | 62.11M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 3.42B |
| Book Value Per Share | 5.71 |
| Working Capital | 378.06M |
Cash Flow
In the last 12 months, operating cash flow was 453.96 million and capital expenditures -187.76 million, giving a free cash flow of 266.20 million.
| Operating Cash Flow | 453.96M |
| Capital Expenditures | -187.76M |
| Depreciation & Amortization | 158.51M |
| Net Borrowing | 79.13M |
| Free Cash Flow | 266.20M |
| FCF Per Share | 0.49 |
Margins
Gross margin is 49.00%, with operating and profit margins of 5.56% and 2.43%.
| Gross Margin | 49.00% |
| Operating Margin | 5.56% |
| Pretax Margin | 2.09% |
| Profit Margin | 2.43% |
| EBITDA Margin | 8.82% |
| EBIT Margin | 5.56% |
| FCF Margin | 5.48% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.45%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 1.45% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 115.94% |
| Buyback Yield | 1.18% |
| Shareholder Yield | 2.62% |
| Earnings Yield | 1.42% |
| FCF Yield | 3.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Sinocare is 22.84, which is 46.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 22.84 |
| Price Target Difference | 46.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 9.77% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 16, 2018. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 16, 2018 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Sinocare has an Altman Z-Score of 4.24 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.24 |
| Piotroski F-Score | 6 |